Metal-phenolic capsules with ROS scavenging reshape the oxidative microenvironment of atherosclerosis

Copyright © 2023 Elsevier Inc. All rights reserved..

Arterial injury makes the tissue in a state of high oxidative stress. At the same time, abnormal lipid metabolism can further lead to bleeding and thrombosis. Therefore, the anti-inflammatory and anti-oxidant polyphenol, EGCG was organically complexed with Fe3+ to form a metal-phenolic framework carrier. And the antihyperlipidemic drug, atorvastatin (ATV) was loaded into the carrier to enhance the bioavailability, and simultaneously alleviate the oxidative stress of the inflammatory site and abnormal lipid metabolism. The results confirmed that the obtained material EGCG-Fe-ATV had good biocompatibility and biosafety effect. In addition, EGCG-Fe-ATV showed outstanding anti-inflammatory, anti-oxidant and lipid-lowering properties. These therapeutic outcomes of EGCG-Fe-ATV were achieved by reducing systemic and local oxidative stress and inflammation, alleviating inflammatory cell infiltration in plaques, and modulating lipid synthesis and transferase to alter cholesterol transport. In conclusion, the combination of metal-phenolic capsules with ATV provides a new strategy for reshaping the oxidative microenvironment of atherosclerosis.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:53

Enthalten in:

Nanomedicine : nanotechnology, biology, and medicine - 53(2023) vom: 10. Sept., Seite 102700

Sprache:

Englisch

Beteiligte Personen:

Zhang, Aiai [VerfasserIn]
Liu, Kaijing [VerfasserIn]
Liang, Xiaoyu [VerfasserIn]
Li, Huiyang [VerfasserIn]
Fu, Xue [VerfasserIn]
Zhu, Ni [VerfasserIn]
Li, Fangjiang [VerfasserIn]
Yang, Jing [VerfasserIn]

Links:

Volltext

Themen:

A0JWA85V8F
Anti-Inflammatory Agents
Anti-inflammation
Anti-oxidant
Antioxidants
Atherosclerosis
Atorvastatin
Capsules
Journal Article
Metal-phenolic framework
ROS scavenging
Reactive Oxygen Species
Research Support, Non-U.S. Gov't

Anmerkungen:

Date Completed 25.09.2023

Date Revised 27.09.2023

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.nano.2023.102700

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM360440223